PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Kirby Institute, University of New South Wales, Australia. Electronic address: r.macintyre@unsw.edu.au.\', \'Psychiatry Department, Public hospital, Melbourne, Victoria, Australia.\', \'GP Emergency Doctor, Australia.\', \'St Vincent\'s Clinical School, University of New South Wales, Australia and University of Notre Dame, Australia.\', \'Western Sydney Local Health District, NSW, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)00872-010.1016/j.vaccine.2021.07.013
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34272095
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34272095>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34272095>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all